Cellectis S.A.
CLLS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $35,172 | $16,725 | $10,655 | $12,717 |
| % Growth | 110.3% | 57% | -16.2% | – |
| Cost of Goods Sold | $2,357 | $2,425 | $2,015 | $2,515 |
| Gross Profit | $32,815 | $14,300 | $8,640 | $10,202 |
| % Margin | 93.3% | 85.5% | 81.1% | 80.2% |
| R&D Expenses | $24,069 | $23,080 | $21,932 | $20,866 |
| G&A Expenses | $2,479 | $2,289 | $2,333 | $934 |
| SG&A Expenses | $2,479 | $2,289 | $2,333 | $934 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,774 | -$1,482 | -$1,446 | -$918 |
| Operating Expenses | $24,774 | $23,887 | $22,819 | $20,882 |
| Operating Income | $8,041 | -$9,587 | -$14,179 | -$10,680 |
| % Margin | 22.9% | -57.3% | -133.1% | -84% |
| Other Income/Exp. Net | -$7,452 | -$14,149 | -$3,948 | $17,117 |
| Pre-Tax Income | $589 | -$23,736 | -$18,127 | $6,437 |
| Tax Expense | $0 | -$1 | $1 | $514 |
| Net Income | $589 | -$23,735 | -$18,128 | $5,922 |
| % Margin | 1.7% | -141.9% | -170.1% | 46.6% |
| EPS | 0.006 | -0.24 | -0.18 | 0.059 |
| % Growth | 102.5% | -33.3% | -404.1% | – |
| EPS Diluted | 0.006 | -0.24 | -0.18 | 0.059 |
| Weighted Avg Shares Out | 100,325 | 100,325 | 100,157 | 100,094 |
| Weighted Avg Shares Out Dil | 100,325 | 100,325 | 100,157 | 100,094 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,313 | $2,223 | $2,912 | $3,545 |
| Interest Expense | $2,107 | $2,082 | $1,911 | $1,711 |
| Depreciation & Amortization | $5,011 | $5,017 | $4,931 | $5,829 |
| EBITDA | $7,707 | -$16,664 | -$11,285 | $14,174 |
| % Margin | 21.9% | -99.6% | -105.9% | 111.5% |